Clesrovimab Effective Against RSV in Healthy Infants

In healthy premature or full-term infants, a single dose of clesrovimab prevents respiratory syncytial virus-associated lower respiratory infections and hospitalizations.
Medscape Medical News

source https://www.medscape.com/viewarticle/single-dose-clesrovimab-provides-protection-against-2025a1000pfz?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension